.png){kind=small}
What it is
TB-500Synthetic peptide derived from thymosin beta-4.
BPC-157Synthetic 15-amino-acid peptide associated with gastric-protection research.
NOVAGENIX · PEPTIDE COMPARISON
TB-500 vs BPC-157: How They Compare & What Research Shows
BPC-157 and TB-500 have attracted interest for their potential roles in tissue repair and recovery. If you are exploring the differences, this guide explains what researchers are studying, the encouraging findings so far, and the questions that human studies still need to answer.
Timothy Mackey, D.O. · NovaGenix Medical Director
Florida license OS9185 · Educational comparison
Medical Director · Physician-led evaluation
PHYSICIAN LED
Individual evaluation
Individual evaluation
FLORIDA
License OS9185
License OS9185
★★★★★
4.9 Google rating
4.9 Google rating
A+ BBB
Accredited business
Accredited business
Novagenix is not a pharmacy or research peptide provider. We do not sell medication directly to patients. We are a physician-led clinic in Jupiter, Florida, and the purpose of this web page is for patient educational purposes. It is important to speak with your primary care provider regarding any medications you may be considering
The short answer
BPC-157
A synthetic 15-amino-acid peptide studied for its role in tissue repair, including tendon healing and collagen organization. Most of what we know comes from laboratory and animal research.
TB-500
A peptide derived from thymosin beta-4, a protein involved in cell movement and tissue repair. Researchers are exploring how these pathways may support healing, while distinguishing TB-500 from the full protein.
Together
Often called the Wolverine Stack, this pairing draws interest because the two peptides influence repair-related pathways. Whether combining them offers an additional benefit in people remains an open research question.
Side-by-side comparison
Proposed pathways
TB-500Cell migration, actin regulation, and tissue remodeling.
BPC-157Angiogenesis, cell survival, and tissue remodeling.
Stage of research
TB-500Early tendon-repair research, including an exploratory animal comparison.
BPC-157Animal research and limited human observations; larger clinical studies are needed.
These pathways help explain the scientific interest. How well they translate into patient outcomes is still being studied. Explore the research and regulatory sources below.
Why are BPC-157 and TB-500 often discussed together?
Both peptides are being studied in connection with the body's repair processes. BPC-157 research explores cell survival, blood-vessel signaling, and collagen remodeling. TB-500 research draws on thymosin beta-4 pathways involved in cell movement and tissue organization.
That overlap explains the interest in using them together as the Wolverine Stack. You may also see BPC-157 described as “local” and TB-500 as “systemic.” These are simplified descriptions, not established clinical rules for choosing a peptide or an injection site. The useful comparison is what each study actually measured.
What the head-to-head animal study found
A 2026 rat Achilles-tendon repair study compared BPC-157, TB-500, the combination, and control under the same conditions. It offers an early look at how the peptides compare in a controlled repair model.
Tendon strength after four weeks: BPC-157 versus TB-500 in a rat Achilles repair model
Median maximum load to failure. Higher values indicate a stronger repaired tendon.
* Adjusted p = 0.0406 versus control.
How to read these findings. All three treatment groups had higher median tendon strength than the control group, with TB-500 versus control reaching statistical significance after correction. This is an encouraging early signal for further research. Differences between the peptide groups were not statistically significant, so this study does not establish a winner or an added benefit from combining them.
ControlMedian: 26.91 NIQR: 26.12–30.44 NReference
BPC-157Median: 37.16 NIQR: 33.01–46.45 NNot significant vs control
TB-500Median: 37.41 NIQR: 37.10–47.82 NAdjusted p = 0.0406 vs control
CombinationMedian: 34.54 NIQR: 33.02–36.24 NNot significant vs control
Source: Biçer O, Adanir O, Güleryüz Y, et al. Joint Diseases and Related Surgery. 2026;37(3):822–837. Read the full study · doi:10.52312/jdrs.2026.2951.
Study context: This was a small, exploratory experiment in healthy young male rats, with four tendons per group tested at one four-week timepoint. It measured repaired-tendon strength rather than everyday function. Human studies are needed to learn whether similar findings translate into better recovery for patients.
Choose medical guidance over research-website purchases
Avoid buying research peptides for personal use
Do not purchase BPC-157, TB-500, or other peptides from research websites for self-treatment. Products labeled “research use only” or “not for human consumption” are intended for laboratory research, not patient care. Online availability, customer reviews, or a purity claim do not establish that a product is appropriate or safe for you.
For injectable products, identity, strength, purity, and sterility are especially important. A research website cannot replace an individual medical evaluation. Learn more about research-use labeling and BPC-157.
Consult your primary care provider or a licensed physician
Before purchasing or using any peptide, schedule a consultation with your primary care provider or a licensed physician. Bring your questions, medical history, and a list of medications and supplements. Your provider can review the evidence, discuss potential interactions and alternatives, and explain whether any option is appropriate and lawfully available for your situation.
If you have already purchased a research product, share the label and ingredient information with your physician before using it. Medical guidance helps you make an informed decision; it does not turn a research product into an approved medicine.
Discuss your questions with NovaGenixWhat to know before considering a peptide
The research is developing, and a conversation with your primary care provider can help put it in the context of your health and goals. Neither BPC-157 nor TB-500 is currently FDA-approved. The FDA’s July 2026 compounding advisory meeting considered these substances, but that process is separate from drug approval. See the FDA meeting record.
- Human safety data, including possible immune reactions, interactions, and long-term effects, remain limited.
- Under WADA rules, BPC-157 and TB-500 are prohibited at all times.
- Athletes should check their governing body's requirements; a prescription alone does not provide a therapeutic-use exemption.
Bring your recovery goals into the conversation
It is understandable to explore new approaches when you want to get back to your usual activities. A useful consultation starts with your symptoms, what you have already tried, and what you hope to improve. Reviewing rehabilitation, training load, sleep, medications, and overall health can help clarify your options and where emerging research fits.
TB-500 evidence review · BPC-157 evidence review · Peptide guide
Frequently asked questions
Which is better?
They have different research backgrounds, and neither has been shown to be better for human injury recovery. BPC-157 has been studied across several tissue-repair models; TB-500 showed a tendon-strength signal in the rat study above. Your diagnosis and goals are more useful starting points than a general ranking.
Can they be used together?
The combination is commonly called the Wolverine Stack. Interest comes from their repair-related pathways, although an additional benefit from combining them has not been established in people. Discuss any treatment you are considering with your primary care provider.
Are either FDA-approved?
Neither currently has FDA approval. Compounding review and drug approval are separate processes.
Is there an established dose or injection site?
Researchers have used different doses and routes, but there is not yet an established human injury-recovery regimen for either peptide. A provider can help you understand why an animal-study dose or an online protocol may not apply to your situation.
Are they allowed in competitive sport?
Under WADA rules, both are prohibited at all times. If you compete, check with your sport's anti-doping organization before considering a peptide.
Research and regulatory sources
- Biçer et al., 2026: Achilles tendon healing in rats — the head-to-head experiment summarized above.
- FDA: July 2026 Pharmacy Compounding Advisory Committee — meeting materials and regulatory context.
- WADA: The Prohibited List — BPC-157 under S0; thymosin beta-4 derivatives including TB-500 under S2.
This guide is intended to help you have an informed conversation with your healthcare provider. Research findings are presented in the context of the populations and outcomes studied.
Have questions about peptides and your health?
Bring your questions and recovery goals to a conversation with NovaGenix. Our physician-led clinic in Jupiter, Florida, can help you understand the research and discuss appropriate next steps for your health.
Request a consultationCall NovaGenix
